NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a live webcast at 3:45 p.m. EDT on Monday, June 6, 2022, with Angela Hwang, Group President, Pfizer Biopharmaceuticals Group, and Aamir Malik, Chief Business Innovation Officer, Executive Vice President, who will discuss expanding access and affordability to … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Skin Grafting System Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Product Type, Type, Wound Type, and End User” report has been added to ResearchAndMarkets.com’s offering. The skin grafting system market is projected to reach US$ 1,348.21 million by 2028 from US$ 832.44 million in 2021; it is estimated … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Frozen Tissues Samples Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product Type, Application and End User” report has been added to ResearchAndMarkets.com’s offering. The frozen tissues samples market is projected to reach US$ 105,045.91 Thousand by 2028 from US$ 44,399.07 Thousand in 2021; it is estimated to grow at … [Read more…]
Regional integrated health system chooses the Innovaccer 2022 Best in KLAS data platform to provide solutions for enhanced provider-patient collaboration and patient engagement. SAN FRANCISCO–(BUSINESS WIRE)–Today, Innovaccer Inc., the Health Cloud company, announced that St. Peter’s Health, a regional nonprofit healthcare system in Helena, Montana, is moving to the InnovaccerⓇ Health Cloud’s Data Activation Platform … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Photoacoustic Tomography Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Geometry, Type, Application and End User” report has been added to ResearchAndMarkets.com’s offering. The photoacoustic tomography market is projected to reach US$ 209.56 million by 2028 from US$ 61.12 million in 2021; it is expected to grow at a CAGR … [Read more…]
BILBAO, Spain–(BUSINESS WIRE)–After 15 years of pioneering R&D efforts in the tumor microenvironment, Oncomatryx announces that the FDA and the Spanish Drug Agency (AEMPS) have cleared its investigational new drug (IND) application for OMTX705, a First-in-Class antibody-drug conjugate (ADC) targeting the tumor microenvironment. OMTX705 is a pioneering ADC that targets, with a novel, dual mechanism … [Read more…]
PEMBROKE, Bermuda–(BUSINESS WIRE)–$AXS #insurance–AXIS Insurance, the specialty insurance business segment of AXIS Capital Holdings Limited (“AXIS Capital”) (NYSE: AXS), today announced it is combining its corporate accident and supplemental health benefits business under a new name, AXIS Group Benefits. The AXIS Group Benefits business portfolio will be managed by the newly expanded team, providing a … [Read more…]
Company to present on extended applications of ultrasensitive liquid biopsy assays at 2022 ASCO in Chicago CHICAGO–(BUSINESS WIRE)–#asco–Lucence, the precision oncology company pioneering ultrasensitive liquid biopsy tests using circulating tumor DNA (ctDNA) and circulating tumor RNA (ctRNA), will present promising new data on the extension of its amplicon-based next generation sequencing (NGS) assays to new … [Read more…]
Collaboration Will Provide Galleri Test to 10,000 Veterans Across the U.S. Over the Next Three Years; VA Pittsburgh Healthcare System Announced as First of Approximately 10 Participating Sites Collaboration is Part of REFLECTION, a Real-World Observational Study Evaluating Performance of Galleri in Clinical Settings MENLO PARK, Calif.–(BUSINESS WIRE)–GRAIL, LLC, a healthcare company whose mission is … [Read more…]
DALLAS–(BUSINESS WIRE)–Nearly 90% of healthcare facilities used locum tenens physicians and/or advanced practice professionals to fill gaps in their staffs last year, according to a new survey from AMN Healthcare, the nation’s leader in total healthcare talent solutions. The company’s 2022 Survey of Locum Tenens Staffing Trends indicates that 88% of hospitals, medical groups, and … [Read more…]
